Key Insights

Highlights

Treatment Research

2 treatments under study, led by Intravitreal Injection Of Bevacizumab

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00407121Phase 3Withdrawn

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

Showing all 1 trials

Research Network

Common Treatments

  • Intravitreal Injection Of Bevacizumab1
  • Bevacizumab1

Active Sponsors

  • Asociación para Evitar la Ceguera en México1

Top Investigators

Related Conditions

  • Vogt Koyanagi Harada Disease1
  • Multifocal Choroiditis1

Activity Timeline